Paper Review Records
All Paper Review Records
4 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
114
days
Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells
Authors
Aditya Venkatesh; Taylor McKenty; Syed Ali; Donna Sonntag; Shobha Ravipaty; Yanyan Cui; Deirdre Slate; Qian Lin; Anne Christiansen; Sarah Jacobson; Jacob Kach; Kian Huat Lim; Vaishnavi Srinivasan; Boris Zinshteyn; Isabel Aznarez; Laryssa A. Huryn; Zhiyu Li; Robert B. Hufnagel; Gene Liau; Karen Anderson; Jeff HogerShow moreShow less
Affiliations
1. Stoke Therapeutics, Bedford, Massachusetts, USA.; 2. Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.Show moreShow less
141
days
Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
Authors
Judith van Deutekom; Chantal Beekman; Suzanne Bijl; Sieto Bosgra; Rani van den Eijnde; Dennis Franken; Bas Groenendaal; Bouchra Harquouli; Anneke Janson; Paul Koevoets; Melissa Mulder; Daan Muilwijk; Galyna Peterburgska; Bianca Querido; Janwillem Testerink; Ruurd Verheul; Peter de Visser; Rudie Weij; Annemieke Aartsma-Rus; Jukka Puoliväli; Timo Bragge; Charles O'Neill; Nicole A. DatsonShow moreShow less
Affiliations
1. VICO Therapeutics B.V., formerly BioMarin Nederland B.V., Leiden, The Netherlands.; 2. Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.; 3. Charles River Discovery Services, Kuopio, Finland.; 4. BioMarin Pharmaceutical, Inc., San Rafael, California, USA.Show moreShow less
117
days
Time Is a Critical Factor When Evaluating Oligonucleotide Therapeutics in hERG Assays
Authors
Yusheng Qu; Robert Kirby; Richard Davies; Ayesha Jinat; Stefano Stabilini; Bin Wu; Longchuan Yu; BaoXi Gao; Hugo M. VargasShow moreShow less
Affiliations
1. Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen, Inc., Thousand Oaks, California, USA.; 2. Metrion Biosciences Ltd, Granta Center, Cambridge, United Kingdom.; 3. Hybrid Modality Engineering, Amgen, Inc., Thousand Oaks, California, USA.; 4. Cardiometabolic Disorders, Amgen, Inc., Thousand Oaks, California, USA.Show moreShow less
35
days
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides
Authors
Annemieke Aartsma-Rus; Alejandro Garanto; Willeke van Roon-Mom; Erin M. McConnell; Victoria Suslovitch; Winston X. Yan; Jonathan K. Watts; Timothy W. YuShow moreShow less
Affiliations
1. Dutch Center for RNA Therapeutics, the Netherlands.; 2. Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.; 3. N = 1 Collaborative.; 4. Department of Pediatrics and Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; 5. Department of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.; 6. RNA Therapeutics Institute, UMass Chan Medical School, Worcester, Massachusetts, USA.; 7. Harvard Medical School, Division of Genetics and Genomics, Boston, Massachusetts, USA.Show moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days